World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 15 January 2024
Main ID:  ISRCTN51495042
Date of registration: 22/04/2016
Prospective Registration: No
Primary sponsor: Västerbotten County Council
Public title: Closing of the hernia defect during laparoscopic ventral hernia repair
Scientific title: Prospective RandOmised Study of Endoscopic fascia Closure and long term Outcome
Date of first enrolment: 18/11/2015
Target sample size: 180
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN51495042
Study type:  Interventional
Study design:  Double-blinded randomized controlled multicenter trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Sweden
Contacts
Name: Mikael    Lindmark
Address:  University Hospital of Umeå (Norrlands Universitetssjukhus) 901 85 Umeå Sweden
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Age >18 years
2. Understand written information in Swedish
3. Primary or incisional hernia of the midline between 2 and 8 cm

Exclusion criteria:
1. Recurrence after previous hernia surgery
2. Laparoscopy not feasible


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Ventral hernia
Digestive System
Intervention(s)

The classic approach in laparoscopic ventral hernia repair is to bridge the hernia defect by reinforcement material. In open techniques, a long- established principle is to, when possible, recreate the anatomy during surgery by suturing of the defect. There is an emerging interest in closing the defect in laparoscopic surgery for ventral hernias before the prosthetic material is applied.

Participants are randomly assigned to one of two groups. They all have a laparoscopic ventral hernia repair, but with the following differences:
Group 1: Undergo suture of hernia defect before application of mesh
Group 2. Mesh is applied without closing of the defect

All participants are then assessed for hernia site complications that occur within 12 months including seroma, hematoma, bulging, mesh migration and infection.

All participants are then assessed for hernia site complications at clinical control after 3 and 12 months. All participants undergo CT scan at 12 months. Hernia site complications include seroma, hematoma, bulging, mesh migration and infection. Biopsy from skin, muscle and fascia are taken and collagen structure will analysed.
Primary Outcome(s)
Hernia site complications within twelve months. This includes recurrence of the hernia, sustained clinically significant seroma, and clinically significant and symptomatic pseudo hernia with sliding of the reinforcing material into the aneurysm sac after twelve months.
Secondary Outcome(s)

1. Abdominal wall pain, assessed using the Ventral Hernia Pain Questionnaire, before surgery, 3 months after surgery and after 12 months
2. Surgical complications within three months of such as infection, and fistula
3. Operating time
4. Abdominal function measured by Biodex after 12 months
Secondary ID(s)
ML2
Source(s) of Monetary Support
Visare Norr (cooperation northern counties), Västerbotten Läns Landsting
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Old ethics approval format; Regional ethics board Umeå (SE), 18/06/2015, ref: 2015-215-32M
Results
Results available: Yes
Date Posted:
Date Completed: 01/11/2021
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history